Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen.
Determination of the amino acid sequence of the immunogenic polypeptides of hepatitis B surface antigen may not only permit molecular localization of the distinct determinants a, d, and y but may also lead to the synthesis of a hapten useful in prophylactic immunization against hepatitis B virus infection. For this purpose, purified monotypic hepatitis B surface antigen of adw subtype was resolved into equal amounts of two major polypeptides (22,000 and 28,000 daltons) and up to six other minor polypeptides by polyacrylamide gel electrophoresis. With the periodate staining reaction, only the 28,000-dalton polypeptide stained as a glycoprotein. Guinea pigs immunized with the 22,000-dalton polypeptide produced potent antisera against determinants a and d, but the 28,000-dalton glycoprotein did not induce a response. Both polypeptides isolated by preparative polyacrylamide gel electrophoresis showed amino acid composition identical with that of the intact antigen. For both polypeptides, hydrazinolysis gave Ile as the carboxyterminus, and carboxypeptidase A digestion gave the same terminal sequence, Val-Tyr-Ile. Both peptides also yielded an identical sequence of amino acids in nine steps of Edman degradation--Met-Glu-Asn-Ile-Thr-Ser(Cys)-Gly-Phe-Leu. Our data suggest that hepatitis B surface antigen contains a single major immunogenic 22,000-dalton polypeptide component, part of which is modified by the addition of carbohydrate to give rise to the glycopeptide of apparent molecular weight 28,000.
D000595:Amino Acid Sequence; D000596:Amino Acids / Q000032:analysis; D002268:Carboxypeptidases; D006511:Hepatitis B Antigens; D006801:Humans; D006834:Hydrazines; D010446:Peptide Fragments / Q000032:analysis; D010455:Peptides
D000596:Amino Acids; D006511:Hepatitis B Antigens; D006834:Hydrazines; D010446:Peptide Fragments; D010455:Peptides; D002268:Carboxypeptidases
Biochim Biophys Acta. 1954 Aug;14(4):533-42
13198911
Life Sci. 1974 Nov 1;15(9):1603-10
4157281
J Biol Stand. 1976;4(4):295-304
993216
J Infect Dis. 1972 Mar;125(3):263-8
4111538
J Virol. 1972 Sep;10(3):469-76
4116138
J Clin Invest. 1973 May;52(5):1176-86
4121700
Science. 1972 Dec 22;178(4067):1300-1
4118259
Ann Intern Med. 1973 Dec;79(6):894-6
4128396
Lancet. 1970 Apr 4;1(7649):695-8
4190997
J Biol Chem. 1974 Apr 10;249(7):2220-7
4362067
Biochemistry. 1971 Jun 22;10(13):2606-17
4326772
JAMA. 1969 Jun 2;208(9):1667-70
4305624
Nature. 1968 Jun 15;218(5146):1057-9
4231935
Am J Med Sci. 1975 Jul-Aug;270(1):123-9
53005
J Biol Chem. 1972 May 10;247(9):2828-34
4554361
Anal Biochem. 1975 Jul;67(1):55-65
167610
Biochim Biophys Acta. 1974 Dec 24;373(3):337-46
4433582
J Virol. 1974 Sep;14(3):572-7
4853069
J Virol. 1974 Aug;14(2):384-91
4847328
Science. 1973 Dec 28;182(4119):1368-71
4796789
J Immunol. 1972 Apr;108(4):1114-8
5023172
Anal Biochem. 1976 May 7;72:353-8
782286
J Immunol. 1975 Sep;115(3):634-9
1151071
Anal Biochem. 1975 May 12;65(1-2):369-79
1130685
Biochemistry. 1971 Dec 21;10(26):4912-21
5134536
J Virol. 1971 May;7(5):569-76
5105002
J Biol Chem. 1969 Oct 25;244(20):5597-607
5348603
Am J Dig Dis. 1969 Mar;14(3):189-94
5773915
J Chromatogr. 1966 Jan;21(1):133-5
5940126